UnitedHealth Group shares rose 3.87% on Wednesday before climbing another 1.17% in after-hours trading, according to Benzinga. The gains followed the announcement of a $2.21 quarterly dividend for September 23rd, payable to shareholders of record by September 15th. The Minnesota-based company’s stock is down about 53% over the past year, with a market capitalization of $246.17 billion. On Friday, the company agreed to sell over 160 healthcare facilities as part of a DOJ settlement related to its $3.3 billion Amedisys acquisition. The company faces challenges with a low P/E ratio of 11.77, a 3.25% dividend yield, and second-quarter earnings of $4.08 that missed estimates and fell from $6.80 last year. Revenue rose 13% to $111.62 billion but missed estimates, and 2025 earnings guidance of at least $16 per share is far below the $22.33 analyst consensus.
